天宇股份(300702) - 2018 Q1 - 季度财报

Financial Performance - Total revenue for Q1 2018 was ¥298,917,193.40, an increase of 4.30% compared to ¥286,586,739.31 in the same period last year[8] - Net profit attributable to shareholders decreased by 34.66% to ¥20,352,087.59 from ¥31,148,070.91 year-on-year[8] - Net profit after deducting non-recurring gains and losses fell by 53.19% to ¥13,544,509.08 compared to ¥28,932,875.66 in the previous year[8] - Basic earnings per share decreased by 51.43% to ¥0.170 from ¥0.350 in the same period last year[8] - The company achieved operating revenue of 298.92 million yuan, an increase of 4.30% compared to the same period last year[25] - The net profit attributable to shareholders was 20.35 million yuan, a decrease of 34.66% compared to the same period last year[25] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 13.54 million yuan, down 53.19% year-on-year[25] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥49,480,376.47, worsening by 43.45% from -¥34,493,598.00 in the previous year[8] - Cash received from tax refunds was 10.20 million yuan, an increase of 80.22% due to higher export tax rebates[24] - Cash received from investment income was 58.76 million yuan, a 193.71% increase attributed to returns on idle raised funds[24] - The company reported a 32.65% increase in cash and cash equivalents, totaling 291.86 million yuan, due to increased fundraising[23] - The cash flow from operating activities for Q1 2018 was negative at -¥49,480,376.47, compared to -¥34,493,598.00 in the same period last year[56] - The company reported a net increase in cash and cash equivalents of 12,352,276.43 CNY, contrasting with a decrease of -7,358,047.15 CNY in the same quarter last year[60] - The ending balance of cash and cash equivalents was 115,542,329.02 CNY, compared to 32,655,914.54 CNY at the end of the previous year, showing a strong liquidity position[60] Shareholder Information - Total number of common shareholders at the end of the reporting period is 23,079[16] - The largest shareholder, Lin Jie, holds 39.96% of shares, totaling 47,951,435 shares[16] - The second largest shareholder, Tu Yongjun, holds 13.91% of shares, totaling 16,686,633 shares[16] - Zhejiang Taizhou Shenting Investment Co., Ltd. holds 6.69% of shares, totaling 8,023,822 shares[16] - The top 10 shareholders collectively hold a significant portion of the company's equity, with the largest three shareholders accounting for over 60%[16] - No repurchase agreements were conducted by the top 10 common shareholders during the reporting period[20] - The total number of restricted shares at the beginning of the period was 90,000,000, with no changes during the reporting period[20] - All restricted shares are subject to a lock-up period ending on September 19, 2020[19] Assets and Liabilities - The company's total assets increased by 6.05% to ¥2,234,157,895.09 from ¥2,106,652,190.74 at the end of the previous year[8] - The total current assets increased to CNY 1,368.56 million from CNY 1,257.40 million, reflecting a growth of approximately 8.83%[40] - The total liabilities increased from CNY 1,020.73 million to CNY 1,368.56 million, indicating a rise of about 34.14%[41] - The company's cash and cash equivalents rose to CNY 291.86 million from CNY 220.03 million, marking an increase of approximately 32.5%[40] - The accounts receivable increased to CNY 218.62 million from CNY 208.40 million, showing a growth of about 4.9%[40] - The inventory level increased to CNY 492.43 million from CNY 461.07 million, reflecting an increase of approximately 6.8%[40] - The fixed assets decreased slightly from CNY 606.18 million to CNY 602.87 million, a decline of about 0.51%[41] Risks and Challenges - The company faces risks from increased market competition and reliance on a concentrated product category, particularly in sartan raw materials[11] - The report was not audited, which may affect the reliability of the financial data presented[61] Investment and Development - The company has not reported any new product developments or market expansions in this quarter[22] - There are no indications of mergers or acquisitions in the current reporting period[22] - The company has no reported violations regarding the use of raised funds[34] - There are no significant changes in the feasibility of the investment projects reported[32]